What level of care for the neurofibromatoses?

Lancet

Volumn 353, Issue 9159, 1999, Pages 1114-1116

  Huson, Susan M ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFIBROMATOSIS; NOTE; PATIENT CARE; PRIORITY JOURNAL;

EID: 0033519006     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)00155-X     Document Type: Note

References (15)

1. Huson S.M. Neurofibromatosis: historical perspective, classification and diagnostic criteria. Huson S.M., Hughes R.A.C. The neurofibromatoses: a clinical and pathogenic overview. 1:1994;1-22 Chapman and Hall, London.
2. Upadhyaya, M., Cooper, D.N., eds. Neurofibromatosis type 1 from genotype to phenotype. Oxford: Bios Scientific Publishers Ltd, 1998.
3. Lutchman M., Rouleau G.A. Neuofibromatosis type 2: a new mechanism of tumour suppression. Trends Neurosci. 19:1996;373-377.
4. Huson, S.M., Evans, D.G.R., Tweedy, R. Neurofibromatosis does it matter? Teaching video and booklet. London: Neurofibromatosis Association, 1997.
5. Listernick R., Lovis D.N., Packer R.J., Gutmann D.H. Optic pathway glioma in children with neurofibromatosis, 1: consensus statement from the Optic Pathway Glioma Task Force. Ann Neurol. 41:1997;143-149.
6. North K.N., Riccard V.M., Samago-Sprouse C.et al. Cognitive function and academic performance in neurofibromatosis type 1: consensus statement from the Nf2 cognitive disorders task force. Neurology. 48:1997;1121-1127.
7. Gutman D.H., Aylsworth A, Carey J.C.et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis type 1 and 2. JAMA. 278:1997;51-57.
8. Moss C., Green S.H. What is segmental neurofibromatosis? Br J Dermatol. 130:1994;106-110.
9. Evans D.G.R., Huson S.M., Neary W.et al. A clinical study of type 2 neurofibromatosis. Q J Med. 304:1992;603-618.
10. Evans D.G.R., Ramsden R., Huson S.M.et al. Type 2 neurofibromatosis: the need for supraregional care? J Laryngol Otol. 107:1993;401-406.
11. Huson S.M., Harper P.S., Compston D.A.S. Von Recklinghausen neurofibromatosis: a clinical and population study in South East Wales. Brain. 111:1988;1355-1381.
12. Benjamin C.M., Colley A., Donnai D., Kingston H., Harris Kerzin-Storrar L. Neurofibromatosis type 1: knowledge, experience and reproductive decisions of affected individuals and families. J Med Genet. 30:1993;567-574.
13. Riccardi V.M. Von Recklinghausen Neurofibromatosis: N Engl J Med. 305:1981;1617-1627.
14. Cnossen M.H., Goede-Golder A.de, van den Broek R.M.et al. A prospective 10 year follow up study of patients with neurofibromatosis type 1. Arch Dis Child. 78:1998;408-412.
15. Wolkenstein P., Frèche B., Zeller J., Revus J. Usefulness of screening investigations in neurofibromatosis type 1: a study of 152 patients. Arch Dermatol. 132:1996;1333-1336.